ArticleInternational journal of molecular sciences2022

Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.

Yixuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.